Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Lett ; 176(1): 75-80, 2002 Feb 08.
Article in English | MEDLINE | ID: mdl-11790456

ABSTRACT

p34(cdc2) is a protein kinase that plays an important role in the control of the cell cycle and regulation of activity of the tumor suppressor gene. Previously, we demonstrated that cisplatin (CDDP) induced growth suppression resulting in differentiation of teratocarcinoma F9 cells. In the present study, we investigated the mechanism of cell cycle retardation by CDDP in F9 cells, focusing on p34(cdc2). After the induction of differentiation with CDDP, F9 cells were arrested at the late S+G2/M. After treatment with CDDP, the level of the expression of cdc2 mRNA did not change. However, the half-life of p34(cdc2) was greatly reduced, thus, the level of p34(cdc2) protein was decreased. These findings suggest that the cell cycle arrest by CDDP is due partly to the induced instability of p34(cdc2) in F9 cells.


Subject(s)
CDC2 Protein Kinase/biosynthesis , CDC2 Protein Kinase/genetics , Cisplatin/pharmacology , Teratocarcinoma/drug therapy , Teratocarcinoma/metabolism , Animals , Antineoplastic Agents/pharmacology , Blotting, Northern , Blotting, Western , Cell Cycle , Mice , Precipitin Tests , RNA, Messenger/metabolism , Time Factors , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...